Option Care Health Files Q2 2024 10-Q
Ticker: OPCH · Form: 10-Q · Filed: Jul 31, 2024 · CIK: 1014739
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
**Option Care Health (OPCH) Q2 10-Q filed. Financials look steady, check balance sheet for details.**
AI Summary
Option Care Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key financial data and balance sheet information as of June 30, 2024, and comparative periods are presented.
Why It Matters
This filing provides investors with a detailed look at Option Care Health's financial health and operational performance during the second quarter of 2024, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks highlighted.
Key Numbers
- 20240630 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 20240731 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Option Care Health, Inc. (company) — Filer of the 10-Q
- BioScrip, Inc. (company) — Former company name
- MIM CORP (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended June 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on July 31, 2024.
What was Option Care Health, Inc.'s former company name?
Option Care Health, Inc. was formerly known as BioScrip, Inc. and MIM CORP.
What is the fiscal year end for Option Care Health, Inc.?
The fiscal year end for Option Care Health, Inc. is December 31.
What is the Standard Industrial Classification (SIC) code for Option Care Health, Inc.?
The SIC code for Option Care Health, Inc. is 8082, which falls under SERVICES-HOME HEALTH CARE SERVICES.
Filing Stats: 4,659 words · 19 min read · ~16 pages · Grade level 13.8 · Accepted 2024-07-31 16:00:52
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share OPCH Nasdaq Global
Filing Documents
- bios-20240630.htm (10-Q) — 1035KB
- opch-ex311x2024063010xq.htm (EX-31.1) — 8KB
- opch-ex312x2024063010xq.htm (EX-31.2) — 8KB
- opch-ex321x2024063010xq.htm (EX-32.1) — 4KB
- opch-ex322x2024063010xq.htm (EX-32.2) — 4KB
- bios-20240630_g1.jpg (GRAPHIC) — 15KB
- 0001014739-24-000035.txt ( ) — 5631KB
- bios-20240630.xsd (EX-101.SCH) — 34KB
- bios-20240630_cal.xml (EX-101.CAL) — 67KB
- bios-20240630_def.xml (EX-101.DEF) — 171KB
- bios-20240630_lab.xml (EX-101.LAB) — 533KB
- bios-20240630_pre.xml (EX-101.PRE) — 363KB
- bios-20240630_htm.xml (XML) — 690KB
Financial Statements
Financial Statements 4 Condensed Consolidated Balance Sheets 5 Unaudited Condensed Consolidated Statements of Comprehensive Income 6 Unaudited Condensed Consolidated Statements of Cash Flows 7 Unaudited Condensed Consolidated Statements of Stockholders' Equity 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 32 Item 4.
Controls and Procedures
Controls and Procedures 32 PART II Item 1.
Legal Proceedings
Legal Proceedings 33 Item 1A.
Risk Factors
Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 33 Item 5. Other Information 34 Item 6. Exhibits 35
SIGNATURES
SIGNATURES 35 2 Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q (this "Form 10-Q") to "Option Care Health," the "Company," "we," "us" and "our" refer to Option Care Health, Inc. and its consolidated subsidiaries.
Forward-Looking Statements
Forward-Looking Statements This Form 10-Q includes forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements concerning our expectations regarding industry and macroeconomic trends and our operating performance. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. If any of these risks materialize, or if any of our assumptions underlying forward-looking statements prove incorrect, actual results and developments may differ materially from those made in or suggested by the forward-looking statements contained in this Form 10-Q. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, those set forth in Item 1A, "Risk Factors," of Part I of our Annual Report on Form 10-K for the year ended December 31, 2023 (our "Form 10-K") filed with the U.S. Securities and Exchange Commission (the "SEC"). Although we have attempted to identify important risk factors, there may be other risk factors not presently known to us or that we presently believe are not material that could cause actual results and developments to differ materially from those made in or sugg
Financial Statements
Item 1. Financial Statements 4 Table of Contents OPTION CARE HEALTH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARES AND PER SHARE AMOUNTS) June 30, 2024 December 31, 2023 (unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $ 376,872 $ 343,849 Accounts receivable, net 468,300 377,658 Inventories 281,421 274,004 Prepaid expenses and other current assets 100,820 98,744 Total current assets 1,227,413 1,094,255 NONCURRENT ASSETS: Property and equipment, net 123,931 120,630 Operating lease right-of-use asset 92,714 84,159 Intangible assets, net 18,542 20,092 Referral sources, net 299,660 315,304 Goodwill 1,540,246 1,540,246 Other noncurrent assets 46,086 42,349 Total noncurrent assets 2,121,179 2,122,780 TOTAL ASSETS $ 3,348,592 $ 3,217,035 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $ 535,688 $ 426,513 Accrued compensation and employee benefits 62,302 92,508 Accrued expenses and other current liabilities 68,959 75,010 Current portion of operating lease liability 21,946 18,278 Current portion of long-term debt 6,512 6,000 Total current liabilities 695,407 618,309 NONCURRENT LIABILITIES: Long-term debt, net of discount, deferred financing costs and current portion 1,105,575 1,056,650 Operating lease liability, net of current portion 91,434 85,484 Deferred income taxes 44,558 34,920 Other noncurrent liabilities 187 — Total noncurrent liabilities 1,241,754 1,177,054 Total liabilities 1,937,161 1,795,363 STOCKHOLDERS' EQUITY: Preferred stock; $ 0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of June 30, 2024 and December 31, 2023 — — Common stock; $ 0.0001 par value: 250,000,000 shares authorized, 183,658,411 shares issued and 171,410,880 shares outstanding as of June 30, 2024; 182,905,559 shares issued and 174,575,537 shares outstanding as of December 31, 2023 18 18 Treasury stock; 12,247,531 and 8,330,022 shares outstanding, at cost,